Show simple item record

dc.contributor.authorHammerschlag, M R
dc.contributor.authorRoblin, P M
dc.date.accessioned2023-06-30T17:10:06Z
dc.date.available2023-06-30T17:10:06Z
dc.date.issued2000-05
dc.identifier.citationHammerschlag MR, Roblin PM. Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Antimicrob Agents Chemother. 2000 May;44(5):1409. doi: 10.1128/AAC.44.5.1409-1409.2000. PMID: 10819727; PMCID: PMC89886.en_US
dc.identifier.issn0066-4804
dc.identifier.pmid10819727
dc.identifier.urihttp://hdl.handle.net/20.500.12648/10352
dc.language.isoenen_US
dc.relation.urlhttps://journals.asm.org/doi/epub/10.1128/aac.44.5.1409-1409.2000en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleMicrobiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleAntimicrobial agents and chemotherapyen_US
dc.source.volume44
dc.source.issue5
dc.source.beginpage1409
dc.source.endpage
dc.source.countryUnited States
dc.description.versionVoRen_US
refterms.dateFOA2023-06-30T17:10:07Z
dc.description.institutionSUNY Downstateen_US
dc.description.departmentPediatricsen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalAntimicrobial agents and chemotherapy
dc.identifier.issue5en_US


Files in this item

Thumbnail
Name:
aac.44.5.1409-1409.2000.pdf
Size:
29.23Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International